| |
| |
|
| Insider
Information: |
Conroy Kevin T |
| Relationship: |
Director |
| City: |
Madison |
| State: |
WI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,347,464 |
|
|
Indirect Shares
|
93,113 |
|
|
| Direct
Value |
$76,587,556 |
|
|
|
Indirect Value
|
$5,479,700 |
|
|
| Total
Shares |
1,440,577 |
|
|
| Total
Value |
$82,067,256 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exact Sciences Corp |
EXAS |
President and CEO, Dir... |
2024-03-01 |
1,299,496 |
2024-03-01 |
93,113 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2018-07-02 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2023-03-06 |
22,968 |
2021-02-14 |
0 |
Premium* |
|
|
Cm Life Sciences Ii Inc. |
SLGC |
Director |
2021-09-01 |
25,000 |
2021-09-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-03-01 |
4 |
AS |
$59.32 |
$490,636 |
D/D |
(8,271) |
1,299,496 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,143 |
1,307,767 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-27 |
4 |
AS |
$56.89 |
$356,302 |
D/D |
(6,263) |
1,289,624 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,181 |
1,295,887 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-23 |
4 |
D |
$57.53 |
$3,541,547 |
D/D |
(61,560) |
1,282,706 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-23 |
4 |
OE |
$13.96 |
$1,435,605 |
D/D |
102,837 |
1,344,266 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-22 |
4 |
AS |
$59.78 |
$691,356 |
D/D |
(11,565) |
1,241,429 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-21 |
4 |
AS |
$61.50 |
$305,963 |
D/D |
(4,975) |
1,229,756 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,238 |
1,252,994 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,374 |
1,234,731 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-15 |
4 |
AS |
$61.43 |
$908,611 |
D/D |
(14,791) |
1,224,357 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,133 |
1,239,148 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-05-01 |
4 |
A |
$30.02 |
$21,284 |
D/D |
709 |
1,208,015 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
14,775 |
22,968 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-28 |
4 |
AS |
$61.12 |
$636,626 |
D/D |
(10,416) |
1,207,306 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,492 |
1,217,722 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-22 |
4 |
AS |
$62.72 |
$298,798 |
D/D |
(4,764) |
1,195,230 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,374 |
1,199,994 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-15 |
4 |
AS |
$65.59 |
$958,729 |
D/D |
(14,617) |
1,189,620 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,132 |
1,204,237 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-13 |
4 |
AS |
$64.55 |
$292,218 |
D/D |
(4,527) |
1,173,105 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,705 |
1,177,632 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-08-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(62,318) |
0 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2022-07-01 |
4 |
AS |
$40.75 |
$285 |
D/D |
(7) |
1,167,927 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-06-30 |
4 |
A |
$1.47 |
$15,000 |
D/D |
10,204 |
62,318 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
